
Aarti Pharmalabs Ltd is Rated Sell by MarketsMOJO
2026-05-19 10:11:09Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read MoreWhen is the next results date for Aarti Pharmalabs Ltd?
2026-05-12 23:17:41The next results date for Aarti Pharmalabs Ltd is scheduled for 18 May 2026....
Read MoreAarti Pharmalabs Declines 4.83% Amid Mixed Technical Signals: 2 Key Factors This Week
2026-05-09 11:01:57Key Events This Week 4 May: Intraday high surge to Rs.797.35 (+7.25%) 5 May: Strong price rally closing at Rs.805.70 (+8.26%) 6 May: Partial recovery to Rs.788.50 (+2.15%) 7 May: Decline to Rs.776.60 (-1.51%) 8 May: Week closes at Rs.766.80 (-1.26%) Week OpenRs.805.70 Week Close</...
Read More
Aarti Pharmalabs Ltd is Rated Sell
2026-05-08 10:10:44Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook.
Read More
Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points
2026-05-04 14:16:03The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals & Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop.
Read More
Aarti Pharmalabs Ltd is Rated Sell
2026-04-27 10:11:18Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read MoreAarti Pharmalabs Gains 1.10%: Technical Shift and Financial Challenges Shape Week
2026-04-18 11:01:01Key Events This Week 13 Apr: Stock opens at Rs.693.75, gains 0.69% despite Sensex decline 15 Apr: MarketsMOJO upgrades rating to Sell; stock rises 1.27% 16 Apr: Technical momentum shifts; stock dips 0.44% amid mixed signals 17 Apr: Week closes at Rs.696.60, down 0.41% on the day Week OpenRs.693.75 Week Close<div class...
Read More
Aarti Pharmalabs Ltd Surges 7.05% to Day's High of Rs 632.55 — Outperforms Sector by 5.98 Percentage Points
2026-04-01 12:01:14The Sensex declined by 2.11% on 1 Apr 2026, while Aarti Pharmalabs Ltd surged 7.05%, marking a remarkable 5.98 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out as a stock-specific event amid a broadly weak market environment.
Read More
Aarti Pharmalabs Ltd is Rated Strong Sell
2026-03-25 10:10:42Aarti Pharmalabs Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
01-Jun-2026 | Source : BSETranscript of Q4 FY 26 Earnings Conference Call.
Audited Financial Results For The Quarter And Financial Year Ended March 31 2026
26-May-2026 | Source : BSEThe Outcome was intimated within the prescribed timelines under various heads however the same was inadvertently missed under Results Tab therefore uploading the same.
Compliances-Reg.24(A)-Annual Secretarial Compliance
26-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the Financial Year 2025-26
Corporate Actions
No Upcoming Board Meetings
Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26
No Splits history available
No Bonus history available
No Rights history available